- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
4 result(s) found for: DOMS.
Displaying page 1 of 1.
EudraCT Number: 2011-004089-13 | Sponsor Protocol Number: KLF/K/019811 | Start Date*: 2012-05-04 | |||||||||||
Sponsor Name:Cassella-med GmbH & Co. KG | |||||||||||||
Full Title: Placebo-controlled exploratory pilot study to investigate the effect and onset of action of Traumaplant® for delayed onset muscle soreness. | |||||||||||||
Medical condition: delayed onset muscle soreness (DOMS) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003139-39 | Sponsor Protocol Number: JAN12006-09 | Start Date*: 2017-05-16 |
Sponsor Name:Spherium Biomed | ||
Full Title: Double-blind, randomized, placebo-controlled, Single-center, Exploratory Clinical Trial to Investigate Safety and Efficacy of COMBOPROFEN for treatment of muscular pain associated with DOMS | ||
Medical condition: Delayed onset muscular soreness | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005003-40 | Sponsor Protocol Number: BTS651/12 | Start Date*: 2013-01-21 |
Sponsor Name:MUCOS Pharma GmbH & Co. KG | ||
Full Title: Effects of Wobenzym® plus in healthy, sportive people after eccentric exercise - a randomized, two-stage, double-blind, placebo-controlled cross-over trial | ||
Medical condition: "Healthy volunteers" Influence of the product on exercise induced muscle damage, noticable in temporal strength loss and muscle soreness. The indication is as defined in the SmPC: Swelling and infl... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000346-30 | Sponsor Protocol Number: CINC424XDE04T | Start Date*: 2015-03-16 | ||||||||||||||||
Sponsor Name:Universität Leipzig | ||||||||||||||||||
Full Title: An open-label, multicenter study of INC424 monotherapy or in combination with azacitidine for patients with post-myeloproliferative disorders (MPD) – AML or with CMML | ||||||||||||||||||
Medical condition: Chronic Myelomonocytic Leukemia and secondary Acute myeloid leukemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
